Prostate Cancer - Results from #22620

New therapeutics to treat castrate-resistant prostate cancer - Abstract July 31, 2013

Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-Year experience at Mount Sinai Medical Center - Abstract July 30, 2013

Serum testosterone levels after medical or surgical androgen deprivation: A comprehensive review of the literature - Abstract July 30, 2013

Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: Results from a pathologically validated series - Abstract July 30, 2013

The role of focal therapy in the management of localised prostate cancer: A systematic review - Abstract July 30, 2013

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population - Abstract July 30, 2013

Pathologic examination of radical prostatectomies in men with very-low-risk disease at biopsy reveals distinct zonal distribution of cancer in African American men - Abstract July 30, 2013

PSA screening for prostate cancer: Why so much controversy? - Abstract July 30, 2013

GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update - Abstract July 30, 2013

Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: A standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics - Abstract July 30, 2013

A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study - Abstract July 30, 2013

Major changes urged for cancer screening and treatment July 30, 2013

Radium-223 chloride (Alpharadin) in patients with bone metastases and castration-resistant prostate cancer (CRPC): A new treatment paradigm - Video lecture by A. Oliver Sartor, MD July 29, 2013

Defining a new testosterone threshold for medical castration: Results from a prospective cohort series - Abstract July 29, 2013

Prostate cancer-specific survival differences in patients treated by radical prostatectomy versus curative radiotherapy - Abstract July 29, 2013

The modified Glasgow prognostic score in prostate cancer: Results from a retrospective clinical series of 744 patients - Abstract July 29, 2013

Abdominal wall haemorrhage after robotic-assisted radical prostatectomy: Is it a complication of robotic surgery? - Abstract July 29, 2013

Transrectal saturation technique may improve cancer detection as an initial prostate biopsy strategy in men with prostate-specific antigen July 29, 2013

Repetitively dosed docetaxel and (153)samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer - Abstract July 29, 2013

FDA Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems July 29, 2013

Page 1132 of 1435